Mechanism studied
Research investigates integrated GIP and GLP-1 receptor signaling, glucose-dependent endocrine responses, appetite-related pathways, gastric emptying, lipid metabolism, and the relative contribution of each receptor.
Tirzepatide
5mg
€50,00
97,79 лв.
Sale price
€50,00
97,79 лв.
Regular price
What is Tirzepatide?
Tirzepatide is a modified 39-amino-acid peptide that activates both GIP and GLP-1 receptors. Approved medicines containing tirzepatide exist, but this Peptara Lab item is an unapproved research material and is not pharmaceutically equivalent.
Identity and scientific context
Tirzepatide is designed as a dual incretin-receptor agonist with affinity for the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. A fatty-acid moiety supports albumin binding in regulated drug formulations.
Areas of interest
Laboratory themes include dual-receptor potency, signaling bias, structure-activity relationships, albumin binding, peptide stability, comparative incretin pharmacology, and controlled metabolic models.
Current evidence level
Tirzepatide has substantial clinical evidence in approved pharmaceutical products. The formulation, manufacturing controls, sterility, excipients, device, and regulatory oversight of those medicines are not transferable to a research vial.
Product presentation and handling
Treat the selected vial amount only as material quantity. Record lot, analytical identity, solvent, concentration, storage, adsorption controls, and assay conditions. Do not derive a clinical dose or schedule from product variants.
Quality and batch documentation
The label, lot number, declared vial amount, and batch-specific documentation are the authoritative references for the supplied material. Any certificate should be matched to the lot number on the vial. A purity result describes analytical composition; it does not establish sterility, clinical safety, or suitability for human use.
Important scientific distinction
Published research about the molecule Tirzepatide describes specific experimental materials, formulations, doses, populations, and controlled conditions. Those findings cannot be transferred automatically to this Peptara Lab research material and are not a promise of clinical effect.
Research use of Tirzepatide
Tirzepatide is supplied exclusively for controlled laboratory and in vitro research. The experimental design, solvent, concentration, and handling procedure must be determined by qualified personnel under an approved institutional protocol.
- Verify identity and lot Check the product label, vial amount, and available batch documentation before beginning work.
- Prepare the workspace Handle only in a clean, controlled laboratory environment using appropriate protective equipment.
- Follow the validated method Use only the solvent, concentration, and procedure specified by your validated research protocol.
- Document storage and disposal Follow the storage conditions on the product label and batch documentation, and minimize exposure to light, heat, moisture, and repeated temperature changes.
Traceability
Record the product title, lot number, vial amount, receipt date, opening date, storage conditions, operator, and experimental use in the laboratory log.
Compatibility and controls
Confirm solvent and container compatibility, use appropriate blanks and reference standards, and document any deviation from the approved method.
For research use only.
Not for human or veterinary use. This product is not a medicine, food, or dietary supplement. No dosing or self-administration instructions are provided.
Shipping and order information
Order processing
Orders are prepared on business days after payment and stock confirmation. You will be contacted if an item requires additional processing time.
Secure packaging
Products are packed to reduce movement, light exposure, and damage during transport. Inspect the parcel and product label after delivery.
Delivery updates
Tracking information is provided when supported by the selected carrier. Delivery time depends on the destination and courier service.
Available delivery methods, final shipping cost, and the latest estimated delivery window are shown at checkout.
Frequently asked questions about Tirzepatide
What is Tirzepatide intended for?
Tirzepatide is offered exclusively for laboratory and in vitro research. It is not intended for human or veterinary use.
What is the main research context for Tirzepatide?
Tirzepatide activates GIP and GLP-1 receptors, whereas retatrutide is designed to add glucagon-receptor activity. They are distinct molecules with different receptor profiles and evidence bases.
Is this a medicine or dietary supplement?
No. Products in this catalog are research materials and are not presented as medicines, foods, cosmetics, or dietary supplements.
How should the product be stored?
Follow the conditions printed on the label and any batch documentation. Keep the container sealed and protect it from light, heat, moisture, contamination, and repeated temperature changes.
How do I choose a product variant?
The variant indicates the amount of material in the vial. Choose only according to the requirements of your validated laboratory protocol; it is not a dosage recommendation.
Can I request batch documentation?
Where batch-specific documentation is available, it can be requested from Peptara Lab support before purchase. Always match any document to the lot number on the received product.
When will an in-stock order be dispatched?
After payment and stock confirmation, in-stock orders are normally prepared for dispatch within 1–2 business days. Courier transit time is separate and depends on destination and service.
What should I do if the parcel or vial arrives damaged?
Do not use the material. Photograph the outer parcel, protective packaging, label, lot number, and damage, keep all packaging, and contact Peptara Lab support promptly for review.
